Hemostemix Inc V.HEM

Alternate Symbol(s): HMTXF

Healthcare Biotechnology

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.

TSXV:HEM - Post by User

Hemostemix Inc > Big players are entering

<< Previous

Bullboard Posts

Next >>

Comment by auricgoldon Dec 26, 2020 11:26am

231 Views

Post# 32183677

RE:Big players are entering

Looks like after we close all the placements and we reach mid point results, we could see this at $0.10 , C$2.00 POST reverse 20:1.

JoshJunior wrote: It looks like some big players are coming into the story. Look at that crazy buying and volume. Someone took out the twos by buying 20 million shares in one shot. Investors don’t do this unless there’s something major going on.
https://hemostemix.com/investor-overview/

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec